729 WASHINGTON AVE. N, MINNEAPOLIS, MN
CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS
Announces Completion of Reverse Stock Split
Forms Strategic Partnership with LongevityFP Technologies, LLC. to Commercialize Epigenetics Technology
Settlement Agreement with J.H. Darbie & Co. - $175,000 Payment
Material Contracts
FOXO Technologies Inc. Increases Authorized Shares to 25 Billion
Majority Stockholder Approves Amendment to Increase Authorized Shares
CFO Departure - Sylwia Nowak Hauman Resigns from FOXO Technologies
Q1
FY 2025
Notice of Late Filing for Annual Report
Q3
Q2
Amended Quarterly Report
Notice of Late Filing for Quarterly Report
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Notice of Exempt Offering of Securities
Direct Registration System
Prospectus filed pursuant to Rule 424(b)(4)
Definitive Information Statement
Preliminary Information Statement
Schedule 13G - Ownership Report
Notification Filed by a National Security Exchange
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Form D Notice of Exempt Offering of Securities
Correspondence
Submission Upload